Last reviewed · How we verify
Recombinant Human Interferon α-2b Spray
Recombinant Human Interferon α-2b Spray is a Small molecule drug developed by Children's Hospital of Fudan University. It is currently FDA-approved.
Recombinant Human Interferon α-2b Spray is a protein-based drug that acts as an agonist to the Interferon alpha/beta receptor. It has been studied in clinical trials for conditions including Novel Coronavirus Pneumonia, 2019-nCoV, and Herpangina.
At a glance
| Generic name | Recombinant Human Interferon α-2b Spray |
|---|---|
| Sponsor | Children's Hospital of Fudan University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) (NA)
- Effect of Recombinant Human Interferon α-2b Spray on Herpangina (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Recombinant Human Interferon α-2b Spray CI brief — competitive landscape report
- Recombinant Human Interferon α-2b Spray updates RSS · CI watch RSS
- Children's Hospital of Fudan University portfolio CI
Frequently asked questions about Recombinant Human Interferon α-2b Spray
What is Recombinant Human Interferon α-2b Spray?
Who makes Recombinant Human Interferon α-2b Spray?
What development phase is Recombinant Human Interferon α-2b Spray in?
Related
- Manufacturer: Children's Hospital of Fudan University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing